MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/md.0000000000003488

Медицинская библиотека · Medicine · 2016

The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.

Chang Ting-Ting, Chen Shiou-Lan, Chang Yun-Hsuan, Chen Po-See, Chu Chun-Hsien, Chen Shih-Heng, Huang San-Yuan, Tzeng Nian-Sheng, Wang Liang-Jen, Wang Tzu-Yun, Li Chia-Ling, Chung Yi-Lun, Hsieh Tsai-Hsin, Lee I-Hui, Chen Kao-Ching, Yang Yen-Kuang, Hong Jau-Shyong, Lu Ru-Band, Lee Sheng-Yu

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

Patients with bipolar II disorder (BDII) have a higher prevalence rate of metabolic disturbance. Whether BDII itself, in addition to its current standard treatment, is a risk factor for metabolic syndrome warrants additional study. The dopamine receptor D3 (DRD3) gene, one of the candidate genes for BDII, is also involved in the dopaminergic system. We investigated whether it is related to changes in the metabolic indices of patients with BDII given 12 weeks of standard treatment.Patients with a first diagnosis of BDII (n = 117) were recruited. Metabolic profiles (cholesterol, triglycerides, fasting serum glucose, body mass index) were measured at baseline and at 2, 8, and 12 weeks. The genotype of the DRD3 Ser9Gly polymorphism (rs6280) was determined. Multiple linear regressions with generalized estimating equation methods were used.Seventy-six (65.0%) patients completed the 12-week intervention. Significant differences in triglyceride change were associated with the DRD3 Ser9Gly genotype (P = 0.03). Patients with the Ser/Ser genotype had significantly smaller triglyceride increases and a lower risk of developing metabolic syndrome than did those with the Ser/Gly+Gly/Gly genotype. However, the associations between the DRD3 Ser9Gly polymorphism with changes in triglyceride level become nonsignificant after correcting for multiple comparisons.We conclude that the DRD3 Ser9Gly polymorphism is nominally associated with changes in triglycerides and metabolic syndrome after 12 weeks of standard BDII treatment.

Для цитирования: Chang Ting-Ting, Chen Shiou-Lan, Chang Yun-Hsuan, Chen Po-See, Chu Chun-Hsien, Chen Shih-Heng, Huang San-Yuan, Tzeng Nian-Sheng, Wang Liang-Jen, Wang Tzu-Yun, Li Chia-Ling, Chung Yi-Lun, Hsieh Tsai-Hsin, Lee I-Hui, Chen Kao-Ching, Yang Yen-Kuang, Hong Jau-Shyong, Lu Ru-Band, Lee Sheng-Yu. The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.. Medicine. 2016. DOI: 10.1097/md.0000000000003488.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.